scholarly article | Q13442814 |
P819 | ADS bibcode | 1984PNAS...81.2864N |
P356 | DOI | 10.1073/PNAS.81.9.2864 |
P932 | PMC publication ID | 345172 |
P698 | PubMed publication ID | 6609369 |
P5875 | ResearchGate publication ID | 16587688 |
P50 | author | Gerald T Nepom | Q38546281 |
P2093 | author name string | Nelson KA | |
Hellström I | |||
Hellström KE | |||
Holbeck SL | |||
P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
Towards a network theory of the immune system. | Q34202813 | ||
Idiotypic regulation of the immune system by the induction of antibodies against anti-idiotypic antibodies | Q35062222 | ||
Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues | Q35312046 | ||
Reduced tumor growth after low-dose irradiation or immunization against blastic suppressor T cells | Q35332092 | ||
Cellular basis of regulation of expression of idiotype. II. Immunity to anti-MOPC-460 idiotype antibodies increases the level of anti-trinitrophenyl antibodies bearing 460 idiotypes | Q36341400 | ||
Antigen- and receptor-driven regulatory mechanisms. III. Induction of delayed type hypersensitivity to azobenzenearsonate with anti-cross-reactive idiotypic antibodies | Q36343517 | ||
Induction of delayed-type hypersensitivity to azobenzenearsonate by a monoclonal anti-idiotype antibody | Q36344610 | ||
Induction of idiotype-bearing, nuclease-specific helper T cells by in vivo treatment with anti-idiotype | Q36345355 | ||
Anti-idiotypes to monoclonal anti-H-2 antibodies. II. Expression of anti-H-2Kk idiotypes on antibodies induced by anti-idiotype or H-2Kk antigen | Q36345797 | ||
Immunization of mice against African trypanosomiasis using anti-idiotypic antibodies | Q36346325 | ||
Induction of antiphosphorylcholine antibody formation by anti-idiotypic antibodies | Q36358575 | ||
Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens | Q36359942 | ||
Suppression of tumor rejection by autologous anti-idiotypic immunity | Q36364815 | ||
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies | Q36411846 | ||
Antigen Receptors of T Helper Cells | Q39444313 | ||
Evidence for the endogenous production of T cell receptors bearing idiotypic determinants | Q39505784 | ||
Suppressor mechanisms in tumor immunity | Q40105810 | ||
Regulation of Immunity to the Azobenzenearsonate Hapten | Q40113197 | ||
The genetic and cellular basis of regulation of the immune response to tumor antigens | Q40296736 | ||
Idiotypic regulation of the immune system. Common idiotypic specificities between idiotypes and antibodies raised against anti-idiotypic antibodies in rabbits | Q40712685 | ||
Properties of Monoclonal Antibodies to Mouse Ig Allotypes, H-2, and Ia Antigens | Q43502452 | ||
Induction or elimination of tumor-specific immunity against a chemically-induced rat tumor using auto-anti-idiotypic immunity | Q44556094 | ||
Genetic control of the immune response to staphylococcal nuclease. XI. Effects of in vivo administration of anti-idiotypic antibodies | Q46561077 | ||
Studies on phosphorylcholine-specific T cell idiotypes and idiotype-specific immunity | Q57138828 | ||
Immunization to a syngeneic sarcoma by a monoclonal auto-anti-idiotypic antibody | Q57159440 | ||
Enhanced detection of immunoglobulin binding by a modified ELISA | Q57159445 | ||
Human melanoma-associated antigen p97 is structurally and functionally related to transferrin | Q59082088 | ||
Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97 | Q70513890 | ||
Induction of anti-H-2 antibodies without alloantigen exposure by in vivo administration of anti-idiotype | Q71548213 | ||
Idiotypes of anti-Ia antibodies. II. Effects of in vivo treatment with xenogeneic anti-idiotype | Q72112671 | ||
Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies | Q72639211 | ||
Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: Possible application to vaccine production | Q72656315 | ||
Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody | Q72657705 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2864-2867 | |
P577 | publication date | 1984-05-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice | |
P478 | volume | 81 |
Q38186146 | Anti-idiotypic antibodies and the induction of specific tumor immunity. |
Q38246921 | Anti-idiotypic tumor vaccines |
Q44160154 | Auto-anti-idiotypic antibodies in mice hyperimmunized with a chemically induced bladder carcinoma |
Q67667074 | Baboon anti-idiotype antibodies mimic a carcinoembryonic antigen epitope |
Q68999327 | Cross-reactive variable-region associated epitopes of human IgG1 lambda paraprotein detected by a monoclonal antibody panel |
Q40204748 | Diagnostic and therapeutic use of monoclonal antibodies to human tumor antigens |
Q36930069 | Epitope- and antigen-specific cancer vaccines |
Q37486766 | Human response against NP-4, a mouse antibody to carcinoembryonic antigen: human anti-idiotype antibodies mimic an epitope on the tumor antigen |
Q40844483 | Human tumor-associated antigen mimicry by anti-idiotypic antibodies. Immunogenicity and clinical trials in patients with solid tumors |
Q47391934 | Idiotypic cascade in the human high molecular weight melanoma‐associated antigen system: Fine specificity and idiotypic profile of anti‐anti‐idiotypic monoclonal antibodies |
Q36996456 | Idiotypic vaccines and infectious diseases. |
Q45170653 | Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A. |
Q37542948 | Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity |
Q36389569 | Polyclonal anti-idiotypic antibodies mimicking the small cell lung carcinoma antigen cluster-5A interact with a panel of antibodies and induce specific immune response in animals |
Q35580948 | Possible role of anti-idiotypic antibodies in the induction of tumor immunity |
Q35228884 | Recent Advances in Antitumor Vaccines |
Q33552626 | Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy |
Q36350167 | Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. |
Q38213740 | The role of the A48 regulatory idiotype in inducing tumor-specific immunity |
Q69845416 | Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies |
Q33920696 | Vaccination against tumor cells expressing breast cancer epithelial tumor antigen. |
Q69751133 | Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge |